Pharmac email crisis: Emailer apologises to Smalley; Chair meets bosses; Calls for CEO sacking
The PM steps into the Pharmac email row, labelling comments 'totally unacceptable'.
The PM steps into the Pharmac email row, labelling comments 'totally unacceptable'.
Financial Times: Strategies focus on ways to insulate China operations, not reduce them.
Adrienne Smithson says her 'world was tipped upside down' after her diagnosis at age 44.
Financial Times: Over 1 billion people worldwide are obese, according to the WHO.
New York Times: Novo Nordisk’s market value has exceeded the size of the Danish economy.
Financial Times: Antimicrobial resistance already kills millions - and it's getting worse.
MyLifeMatters collective represents over a million patients with life-limiting conditions.
OPINION: Drug-buying agency has received huge criticism. For what?
OPINION: Why your support for the Cancer Society's Daffodil Day matters.
John Collett moved the methadone to a small bottle, then put it in his pocket.
Telegraph: 'I never expected a licensed drug to make me feel so bad.'
Postpartum depression can continue for months or even years.
For many, just driving to the pharmacy is a significant barrier.
Telegraph: Yes, semaglutide works. But there's a price to pay, says a UK patient.
New York Times: The weight-loss equation changes for older adults, experts say.
Telegraph: A new study points the finger at a little-known hormone called GDF15.
Life Pharmacy and Unichem are having to lower their prices.
The Council of Medical Colleges want to stop the advertisement of medicines.
Sensitive refurbishment and amalgamation of the buildings takes prize.
Telegraph: Jack Rear started taking finasteride even though he wasn't sure he needed it.
New York Times: Once-deadly diseases are now survivable, writes Kate Pickert.
New York Times: Katarra Ewing's experience isn't uncommon, obesity experts say.
Telegraph: A new doco casts an unflattering light on reproductive healthcare for women.
NZ has reciprocal health agreements with the UK and Oz, National not impressed.
Opinion: Barriers remain after $5 co-payment charge is gone.
Telegraph: Drugs won't solve the world's obesity problem, says Professor Roy Taylor.
The Government has abolished most charges, but some remain.
The decision, announced as part of Budget 2023, will cost the Government $619m.
Medsafe says an audit found a "significant number of non-compliance issues".
Northland women going through menopause are starting to suffer due to an HRT shortage.